Phosphodiesterase-5 (PDE5) Inhibitors drug molecules are used to treat pulmonary hypertension and erectile dysfunction that exhibit poor aqueous solubility, low dissolution rate, which presents major challenges to develop into formulation. This evidence concerns the gene PDE5A and erectile dysfunction.